SUBSCRIBE
SUBSCRIBE
News   Business

IsoRay, Inc. Announces Distribution Agreement with BrachySciences

February 18, 2009 | 
1 min read
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay Inc. (AMEX: ISR) today announced it has signed an agreement with BrachySciences, a division of Biocompatibles International plc (LSE: BII), to distribute IsoRay’s Proxcelan Cesium-131 brachytherapy seeds.
Alliances
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Following Cancelled FDA Meeting, Kezar To Cut Employees, Eyes Strategic Alternatives
October 17, 2025
 · 
73 min read
 · 
BioSpace Editorial Staff
background, no people
Drug pricing
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic
October 17, 2025
 · 
3 min read
 · 
Annalee Armstrong
Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac